Y. Elamin, M. Nagasaka, E. Shum, L. Bazhenova, J. Rotow, D. Spigel, D. Tan, A. Zalutskaya, F. Albayya, K. Reckamp
{"title":"BLU-945 单药治疗和与奥希替尼联合治疗曾接受过治疗的晚期表皮生长因子受体突变型 (EGFRm) NSCLC 患者的 1/2 期 SYMPHONY 研究","authors":"Y. Elamin, M. Nagasaka, E. Shum, L. Bazhenova, J. Rotow, D. Spigel, D. Tan, A. Zalutskaya, F. Albayya, K. Reckamp","doi":"10.1016/j.jlb.2023.100125","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":509533,"journal":{"name":"The Journal of Liquid Biopsy","volume":"32 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"BLU-945 Monotherapy and Combination With Osimertinib in Previously Treated Patients With Advanced EGFR-Mutant (EGFRm) NSCLC in Phase 1/2 SYMPHONY Study\",\"authors\":\"Y. Elamin, M. Nagasaka, E. Shum, L. Bazhenova, J. Rotow, D. Spigel, D. Tan, A. Zalutskaya, F. Albayya, K. Reckamp\",\"doi\":\"10.1016/j.jlb.2023.100125\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":509533,\"journal\":{\"name\":\"The Journal of Liquid Biopsy\",\"volume\":\"32 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Journal of Liquid Biopsy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jlb.2023.100125\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Liquid Biopsy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.jlb.2023.100125","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
BLU-945 Monotherapy and Combination With Osimertinib in Previously Treated Patients With Advanced EGFR-Mutant (EGFRm) NSCLC in Phase 1/2 SYMPHONY Study